Steven M. Paul, Director at Rapport Therapeutics, Inc. (RAPP), bought 55,048 shares at $24.50 ($1.4M) on 2025-09-12, disclosed to the SEC on 2025-09-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.50 | 28,284 | $693K | 50.9% |
| 2 | $24.97 | 13,382 | $334K | 24.5% |
| 3 | $24.97 | 13,382 | $334K | 24.5% |
| Total | $24.73 avg | 55,048 | $1.4M | 100% |
| Filing → |
| ALNY | SELL | 2020-12-22 | $2.1M | — | Filing → |
| KRTX | SELL | 2020-06-30 | $60.5M | — | Filing → |
| ALNY | SELL | 2020-02-11 | $3.9M | — | Filing → |